Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 261

1.

Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort.

Katelaris AL, Jackson C, Southern J, Gupta RK, Drobniewski F, Lalvani A, Lipman M, Mangtani P, Abubakar I.

J Infect Dis. 2019 Aug 29. pii: jiz430. doi: 10.1093/infdis/jiz430. [Epub ahead of print]

PMID:
31504674
2.

Whole genome sequencing identifies bacterial factors affecting transmission of multidrug-resistant tuberculosis in a high-prevalence setting.

Dixit A, Freschi L, Vargas R, Calderon R, Sacchettini J, Drobniewski F, Galea JT, Contreras C, Yataco R, Zhang Z, Lecca L, Kolokotronis SO, Mathema B, Farhat MR.

Sci Rep. 2019 Apr 3;9(1):5602. doi: 10.1038/s41598-019-41967-8.

3.

Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.

Abubakar I, Lalvani A, Southern J, Sitch A, Jackson C, Onyimadu O, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Kon OM, Hayward A, Lord J, Drobniewski F.

Health Technol Assess. 2018 Oct;22(56):1-96. doi: 10.3310/hta22560.

4.

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, Bi L, Beckert P, Bonnet M, Bradley P, Cabibbe AM, Cancino-Muñoz I, Caulfield MJ, Chaiprasert A, Cirillo DM, Clifton DA, Comas I, Crook DW, De Filippo MR, de Neeling H, Diel R, Drobniewski FA, Faksri K, Farhat MR, Fleming J, Fowler P, Fowler TA, Gao Q, Gardy J, Gascoyne-Binzi D, Gibertoni-Cruz AL, Gil-Brusola A, Golubchik T, Gonzalo X, Grandjean L, He G, Guthrie JL, Hoosdally S, Hunt M, Iqbal Z, Ismail N, Johnston J, Khanzada FM, Khor CC, Kohl TA, Kong C, Lipworth S, Liu Q, Maphalala G, Martinez E, Mathys V, Merker M, Miotto P, Mistry N, Moore DAJ, Murray M, Niemann S, Omar SV, Ong RT, Peto TEA, Posey JE, Prammananan T, Pym A, Rodrigues C, Rodrigues M, Rodwell T, Rossolini GM, Sánchez Padilla E, Schito M, Shen X, Shendure J, Sintchenko V, Sloutsky A, Smith EG, Snyder M, Soetaert K, Starks AM, Supply P, Suriyapol P, Tahseen S, Tang P, Teo YY, Thuong TNT, Thwaites G, Tortoli E, van Soolingen D, Walker AS, Walker TM, Wilcox M, Wilson DJ, Wyllie D, Yang Y, Zhang H, Zhao Y, Zhu B.

N Engl J Med. 2018 Oct 11;379(15):1403-1415. doi: 10.1056/NEJMoa1800474. Epub 2018 Sep 26.

5.

Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.

Abubakar I, Drobniewski F, Southern J, Sitch AJ, Jackson C, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Lynn W, Burgess H, Mann B, Imran A, Sridhar S, Tsou CY, Nikolayevskyy V, Rees-Roberts M, Whitworth H, Kon OM, Haldar P, Kunst H, Anderson S, Hayward A, Watson JM, Milburn H, Lalvani A; PREDICT Study Team.

Lancet Infect Dis. 2018 Oct;18(10):1077-1087. doi: 10.1016/S1473-3099(18)30355-4. Epub 2018 Aug 30.

6.

Should all suspected tuberculosis cases in high income countries be tested with GeneXpert?

Vella V, Broda A, Drobniewski F.

Tuberculosis (Edinb). 2018 May;110:112-120. doi: 10.1016/j.tube.2017.10.006. Epub 2017 Nov 8.

7.

Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort.

Jackson C, Southern J, Lalvani A, Drobniewski F, Griffiths CJ, Lipman M, Bothamley GH, Deeks JJ, Imran A, Kon OM, Mpofu S, Nikolayevskyy V, Rees-Roberts M, Sitch A, Sridhar S, Tsou CY, Whitworth H, Abubakar I.

Thorax. 2019 Jan;74(1):91-94. doi: 10.1136/thoraxjnl-2017-211124. Epub 2018 May 15.

8.

The use of whole-genome sequencing in cluster investigation of a multidrug-resistant tuberculosis outbreak.

Lalor MK, Casali N, Walker TM, Anderson LF, Davidson JA, Ratna N, Mullarkey C, Gent M, Foster K, Brown T, Magee J, Barrett A, Crook DW, Drobniewski F, Thomas HL, Abubakar I.

Eur Respir J. 2018 Jun 21;51(6). pii: 1702313. doi: 10.1183/13993003.02313-2017. Print 2018 Jun.

PMID:
29748309
9.

Mycobacterium avium lysate induces matrix metalloproteinase-1 in intestinal tissue and peripheral blood: Observations from selected hospital based Zambian adults.

Chongwe G, Michelo C, Sinkala E, Kayamba V, Nzayisenga JB, Drobniewski F, Kelly P.

Int J Infect Dis. 2018 Jun;71:73-81. doi: 10.1016/j.ijid.2018.03.020. Epub 2018 Apr 20.

10.

Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates.

Broda A, Nikolayevskyy V, Casali N, Khan H, Bowker R, Blackwell G, Patel B, Hume J, Hussain W, Drobniewski F.

Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1273-1279. doi: 10.1007/s10096-018-3246-2. Epub 2018 Apr 20.

11.

Time-and-motion tool for the assessment of working time in tuberculosis laboratories: a multicentre study.

Mathys V, Roycroft E, Raftery P, Groenheit R, Folkvardsen DB, Homorodean D, Vasiliauskiene E, Vasiliauskaite L, Kodmon C, van der Werf MJ, Drobniewski F, Nikolayevskyy V.

Int J Tuberc Lung Dis. 2018 Apr 1;22(4):444-451. doi: 10.5588/ijtld.17.0564.

12.

Tracking and responding to an outbreak of tuberculosis using MIRU-VNTR genotyping and whole genome sequencing as epidemiological tools.

Black AT, Hamblion EL, Buttivant H, Anderson SR, Stone M, Casali N, Drobniewski F, Nwoguh F, Marshall BG, Booth L.

J Public Health (Oxf). 2018 Jun 1;40(2):e66-e73. doi: 10.1093/pubmed/fdx075.

PMID:
29106587
13.

Fighting drug-resistant tuberculosis in eastern Europe.

Drobniewski F, Ehsani S, Dara M.

Lancet Infect Dis. 2017 Jul;17(7):691-692. doi: 10.1016/S1473-3099(17)30330-4. Epub 2017 Jun 21. No abstract available.

14.

Multidrug-resistant TB in Eastern region of the EU: is the shorter regimen an exception or a rule?

Balabanova Y, Fiebig L, Ignatyeva O, Riekstina V, Danilovits M, Jaama K, Davidaviciene E, Radiulyte B, Popa CM, Nikolayevskyy V, Drobniewski F.

Thorax. 2017 Sep;72(9):850-852. doi: 10.1136/thoraxjnl-2016-209841. Epub 2017 Feb 16.

PMID:
28209653
15.

A Bioengineered Three-Dimensional Cell Culture Platform Integrated with Microfluidics To Address Antimicrobial Resistance in Tuberculosis.

Bielecka MK, Tezera LB, Zmijan R, Drobniewski F, Zhang X, Jayasinghe S, Elkington P.

MBio. 2017 Feb 7;8(1). pii: e02073-16. doi: 10.1128/mBio.02073-16.

16.

pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis.

Zheng X, Ning Z, Drobniewski F, Yang J, Li Q, Zhang Z, Hu Y.

Int J Antimicrob Agents. 2017 Feb;49(2):183-188. doi: 10.1016/j.ijantimicag.2016.10.012. Epub 2016 Nov 24.

PMID:
28012685
17.

Tuberculosis cases caused by heterogeneous infection in Eastern Europe and their influence on outcomes.

Kontsevaya I, Nikolayevskyy V, Kovalyov A, Ignatyeva O, Sadykhova A, Simak T, Tikhonova O, Dubrovskaya Y, Vasiliauskiene E, Davidaviciene E, Skenders G, Makurina O, Balabanova Y, Drobniewski F.

Infect Genet Evol. 2017 Mar;48:76-82. doi: 10.1016/j.meegid.2016.12.016. Epub 2016 Dec 18.

18.

True rifampicin resistance missed by the MGIT: prevalence of this pheno/genotype in the UK and Ireland after 18 month surveillance.

Gonzalo X, Claxton P, Brown T, Montgomery L, Fitzgibbon M, Laurenson I, Drobniewski F.

Clin Microbiol Infect. 2017 Apr;23(4):260-263. doi: 10.1016/j.cmi.2016.11.015. Epub 2016 Nov 27.

19.

Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review.

Papaventsis D, Casali N, Kontsevaya I, Drobniewski F, Cirillo DM, Nikolayevskyy V.

Clin Microbiol Infect. 2017 Feb;23(2):61-68. doi: 10.1016/j.cmi.2016.09.008. Epub 2016 Sep 22. Review.

20.

Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational Study.

Casali N, Broda A, Harris SR, Parkhill J, Brown T, Drobniewski F.

PLoS Med. 2016 Oct 4;13(10):e1002137. doi: 10.1371/journal.pmed.1002137. eCollection 2016 Oct.

21.

Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.

Li D, Hu Y, Werngren J, Mansjö M, Zheng X, Drobniewski F, Hoffner S, Xu B.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5159-66. doi: 10.1128/AAC.02687-15. Print 2016 Sep.

22.

Whole genome sequencing of Mycobacterium tuberculosis for detection of recent transmission and tracing outbreaks: A systematic review.

Nikolayevskyy V, Kranzer K, Niemann S, Drobniewski F.

Tuberculosis (Edinb). 2016 May;98:77-85. doi: 10.1016/j.tube.2016.02.009. Epub 2016 Mar 10. Review.

23.

External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study.

Nikolayevskyy V, Hillemann D, Richter E, Ahmed N, van der Werf MJ, Kodmon C, Drobniewski F, Ruesch-Gerdes S; ERLTB-Net Network.

PLoS One. 2016 Apr 7;11(4):e0152926. doi: 10.1371/journal.pone.0152926. eCollection 2016.

24.

Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference?

Balabanova Y, Ignatyeva O, Fiebig L, Riekstina V, Danilovits M, Jaama K, Davidaviciene E, Radiulyte B, Popa CM, Nikolayevskyy V, Drobniewski F.

Thorax. 2016 Sep;71(9):854-61. doi: 10.1136/thoraxjnl-2015-207638. Epub 2016 Mar 24.

25.

MIRU-VNTR Genotyping of Mycobacterium tuberculosis Strains Using QIAxcel Technology: A Multicentre Evaluation Study.

Nikolayevskyy V, Trovato A, Broda A, Borroni E, Cirillo D, Drobniewski F.

PLoS One. 2016 Mar 3;11(3):e0149435. doi: 10.1371/journal.pone.0149435. eCollection 2016.

26.

Evaluation of Xpert MTB/RIF for Detection of Mycobacterium tuberculosis in Cerebrospinal Fluid.

Pink F, Brown TJ, Kranzer K, Drobniewski F.

J Clin Microbiol. 2016 Mar;54(3):809-11. doi: 10.1128/JCM.02806-15. Epub 2016 Jan 13.

27.

A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.

Kranzer K, Elamin WF, Cox H, Seddon JA, Ford N, Drobniewski F.

Thorax. 2015 Nov;70(11):1070-7. doi: 10.1136/thoraxjnl-2015-207245. Epub 2015 Sep 7. Review.

PMID:
26347391
28.

Beijing clades of Mycobacterium tuberculosis are associated with differential survival in HIV-negative Russian patients.

Balabanova Y, Nikolayevskyy V, Ignatyeva O, Kontsevaya I, Mironova S, Kovalyov A, Kritsky A, Rodionova Y, Fedorin I, Casali N, Hooper R, Horstmann RD, Nejentsev S, Hoffner S, Nuernberg P, Drobniewski F.

Infect Genet Evol. 2015 Dec;36:517-523. doi: 10.1016/j.meegid.2015.08.028. Epub 2015 Aug 28.

PMID:
26319998
29.

Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs.

Barrera L, Cooreman E, de Dieu Iragena J, Drobniewski F, Duda P, Havelkova M, Hoffner S, Kam KM, Kim SJ, Labelle S, Lambregts K, Leimane V, Nunn P, Ramsay A, Raviglione M, Rich M, Ridderhof J, Rodrigues F, Rüsch-Gerdes S, Salfinger M, Scholten J, Selvakumar N, Shinnick T, Shul'gina M, Šķenders G, Sloutsky A, Small P, Van Deun A, Varaine F, Yagui M, Vincent V, Weyer K, Wright A, Zignol M.

Geneva: World Health Organization; 2008.

30.

Lab-on-Chip-Based Platform for Fast Molecular Diagnosis of Multidrug-Resistant Tuberculosis.

Cabibbe AM, Miotto P, Moure R, Alcaide F, Feuerriegel S, Pozzi G, Nikolayevskyy V, Drobniewski F, Niemann S, Reither K, Cirillo DM; TM-REST Consortium; TB-CHILD Consortium.

J Clin Microbiol. 2015 Dec;53(12):3876-80. doi: 10.1128/JCM.01824-15. Epub 2015 Aug 5.

31.

Resistance profile and risk factors of drug resistant tuberculosis in the Baltic countries.

Ignatyeva O, Balabanova Y, Nikolayevskyy V, Koshkarova E, Radiulyte B, Davidaviciene E, Riekstina V, Jaama K, Danilovits M, Popa CM, Drobniewski FA.

Tuberculosis (Edinb). 2015 Sep;95(5):581-8. doi: 10.1016/j.tube.2015.05.018. Epub 2015 Jun 24.

PMID:
26164355
32.

Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study.

Walker TM, Kohl TA, Omar SV, Hedge J, Del Ojo Elias C, Bradley P, Iqbal Z, Feuerriegel S, Niehaus KE, Wilson DJ, Clifton DA, Kapatai G, Ip CLC, Bowden R, Drobniewski FA, Allix-Béguec C, Gaudin C, Parkhill J, Diel R, Supply P, Crook DW, Smith EG, Walker AS, Ismail N, Niemann S, Peto TEA; Modernizing Medical Microbiology (MMM) Informatics Group.

Lancet Infect Dis. 2015 Oct;15(10):1193-1202. doi: 10.1016/S1473-3099(15)00062-6. Epub 2015 Jun 23. Erratum in: Lancet Infect Dis. 2017 Nov 21;:.

33.

The oral mucosal and salivary microbial community of Behçet's syndrome and recurrent aphthous stomatitis.

Seoudi N, Bergmeier LA, Drobniewski F, Paster B, Fortune F.

J Oral Microbiol. 2015 Jun 1;7:27150. doi: 10.3402/jom.v7.27150. eCollection 2015.

34.

Fatal nosocomial MDR TB identified through routine genetic analysis and whole-genome sequencing.

Williams OM, Abeel T, Casali N, Cohen K, Pym AS, Mungall SB, Desjardins CA, Banerjee A, Drobniewski F, Earl AM, Cooke GS.

Emerg Infect Dis. 2015 Jun;21(6):1082-4. doi: 10.3201/eid2106.141903. No abstract available.

35.

Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples.

Brown AC, Bryant JM, Einer-Jensen K, Holdstock J, Houniet DT, Chan JZ, Depledge DP, Nikolayevskyy V, Broda A, Stone MJ, Christiansen MT, Williams R, McAndrew MB, Tutill H, Brown J, Melzer M, Rosmarin C, McHugh TD, Shorten RJ, Drobniewski F, Speight G, Breuer J.

J Clin Microbiol. 2015 Jul;53(7):2230-7. doi: 10.1128/JCM.00486-15. Epub 2015 May 13.

36.

Vitamin D supplementation: a comprehensive review on supplementation for tuberculosis prophylaxis.

Turnbull ER, Drobniewski F.

Expert Rev Respir Med. 2015 Jun;9(3):269-75. doi: 10.1586/17476348.2015.1042458. Epub 2015 May 9. Review.

37.

Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis.

Drobniewski F, Cooke M, Jordan J, Casali N, Mugwagwa T, Broda A, Townsend C, Sivaramakrishnan A, Green N, Jit M, Lipman M, Lord J, White PJ, Abubakar I.

Health Technol Assess. 2015 May;19(34):1-188, vii-viii. doi: 10.3310/hta19340. Review.

38.

Correlates between models of virulence for Mycobacterium tuberculosis among isolates of the Central Asian lineage: a case for lysozyme resistance testing?

Pardieu C, Casali N, Clark SO, Hooper R, Williams A, Velji P, Gonzalo X, Drobniewski F.

Infect Immun. 2015 Jun;83(6):2213-23. doi: 10.1128/IAI.03080-14. Epub 2015 Mar 16.

39.

Susceptibility to tuberculosis is associated with variants in the ASAP1 gene encoding a regulator of dendritic cell migration.

Curtis J, Luo Y, Zenner HL, Cuchet-Lourenço D, Wu C, Lo K, Maes M, Alisaac A, Stebbings E, Liu JZ, Kopanitsa L, Ignatyeva O, Balabanova Y, Nikolayevskyy V, Baessmann I, Thye T, Meyer CG, Nürnberg P, Horstmann RD, Drobniewski F, Plagnol V, Barrett JC, Nejentsev S.

Nat Genet. 2015 May;47(5):523-527. doi: 10.1038/ng.3248. Epub 2015 Mar 16.

40.

Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis.

Gonzalo X, Casali N, Broda A, Pardieu C, Drobniewski F.

Int J Antimicrob Agents. 2015 Apr;45(4):406-12. doi: 10.1016/j.ijantimicag.2014.11.017. Epub 2015 Feb 2.

PMID:
25717028
41.

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage.

Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, Blum MG, Rüsch-Gerdes S, Mokrousov I, Aleksic E, Allix-Béguec C, Antierens A, Augustynowicz-Kopeć E, Ballif M, Barletta F, Beck HP, Barry CE 3rd, Bonnet M, Borroni E, Campos-Herrero I, Cirillo D, Cox H, Crowe S, Crudu V, Diel R, Drobniewski F, Fauville-Dufaux M, Gagneux S, Ghebremichael S, Hanekom M, Hoffner S, Jiao WW, Kalon S, Kohl TA, Kontsevaya I, Lillebæk T, Maeda S, Nikolayevskyy V, Rasmussen M, Rastogi N, Samper S, Sanchez-Padilla E, Savic B, Shamputa IC, Shen A, Sng LH, Stakenas P, Toit K, Varaine F, Vukovic D, Wahl C, Warren R, Supply P, Niemann S, Wirth T.

Nat Genet. 2015 Mar;47(3):242-9. doi: 10.1038/ng.3195. Epub 2015 Jan 19.

PMID:
25599400
42.

Utility of propidium monoazide viability assay as a biomarker for a tuberculosis disease.

Nikolayevskyy V, Miotto P, Pimkina E, Balabanova Y, Kontsevaya I, Ignatyeva O, Ambrosi A, Skenders G, Ambrozaitis A, Kovalyov A, Sadykhova A, Simak T, Kritsky A, Mironova S, Tikhonova O, Dubrovskaya Y, Rodionova Y, Cirillo D, Drobniewski F.

Tuberculosis (Edinb). 2015 Mar;95(2):179-85. doi: 10.1016/j.tube.2014.11.005. Epub 2014 Dec 9.

PMID:
25534168
43.

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.

Miotto P, Cabibbe AM, Feuerriegel S, Casali N, Drobniewski F, Rodionova Y, Bakonyte D, Stakenas P, Pimkina E, Augustynowicz-Kopeć E, Degano M, Ambrosi A, Hoffner S, Mansjö M, Werngren J, Rüsch-Gerdes S, Niemann S, Cirillo DM.

MBio. 2014 Oct 21;5(5):e01819-14. doi: 10.1128/mBio.01819-14.

44.

Enhanced tuberculosis outbreak investigation using whole genome sequencing and IGRA.

Smit PW, Vasankari T, Aaltonen H, Haanperä M, Casali N, Marttila H, Marttila J, Ojanen P, Ruohola A, Ruutu P, Drobniewski F, Lyytikäinen O, Soini H.

Eur Respir J. 2015 Jan;45(1):276-9. doi: 10.1183/09031936.00125914. Epub 2014 Oct 16. No abstract available.

45.

Heterogeneity of phenotypic characteristics of the modern and ancestral Beijing strains of Mycobacterium tuberculosis.

Faksri K, Chaiprasert A, Pardieu C, Casali N, Palaga T, Prammananan T, Palittapongarnpim P, Prayoonwiwat N, Drobniewski F.

Asian Pac J Allergy Immunol. 2014 Jun;32(2):124-32. doi: 10.12932/AP0361.32.2.2013.

46.

Evaluation of a biphasic media assay for pyrazinamide drug susceptibility testing of Mycobacterium tuberculosis.

Gonzalo X, Drobniewski F, Hoffner S, Werngren J.

J Antimicrob Chemother. 2014 Nov;69(11):3001-5. doi: 10.1093/jac/dku230. Epub 2014 Jun 23.

PMID:
24962032
47.

Multidrug-resistant tuberculosis in the United Kingdom and Lithuania.

Gonzalo X, Hutchison DC, Drobniewski FA, Pimkina E, Davidaviciene E.

Int J Tuberc Lung Dis. 2014 Jun;18(6):663-5. doi: 10.5588/ijtld.13.0342.

PMID:
24903935
48.

Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational study.

Walker TM, Lalor MK, Broda A, Ortega LS, Morgan M, Parker L, Churchill S, Bennett K, Golubchik T, Giess AP, Del Ojo Elias C, Jeffery KJ, Bowler ICJW, Laurenson IF, Barrett A, Drobniewski F, McCarthy ND, Anderson LF, Abubakar I, Thomas HL, Monk P, Smith EG, Walker AS, Crook DW, Peto TEA, Conlon CP.

Lancet Respir Med. 2014 Apr;2(4):285-292. doi: 10.1016/S2213-2600(14)70027-X. Epub 2014 Mar 4.

49.

Laboratory diagnosis of paediatric tuberculosis in the European Union/European Economic Area: analysis of routine laboratory data, 2007 to 2011.

Sanchini A, Fiebig L, Drobniewski F, Haas W, Richter E, Katalinic-Jankovic V, Pimkina E, Skenders G, Cirillo DM; European Reference Laboratory Network for TB Members, Balabanova Y.

Euro Surveill. 2014 Mar 20;19(11). pii: 20744.

50.

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.

Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET.

Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

Supplemental Content

Loading ...
Support Center